nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2C—metabolic syndrome X	0.796	1	CbGaD
Lisuride—HTR2A—arteriole—metabolic syndrome X	0.00823	0.147	CbGeAlD
Lisuride—HTR2A—sympathetic nervous system—metabolic syndrome X	0.00524	0.0934	CbGeAlD
Lisuride—HTR1B—artery—metabolic syndrome X	0.00415	0.074	CbGeAlD
Lisuride—HTR1D—artery—metabolic syndrome X	0.00402	0.0717	CbGeAlD
Lisuride—HTR2A—autonomic nervous system—metabolic syndrome X	0.00352	0.0628	CbGeAlD
Lisuride—HTR1B—blood vessel—metabolic syndrome X	0.00324	0.0577	CbGeAlD
Lisuride—HTR1D—blood vessel—metabolic syndrome X	0.00313	0.0558	CbGeAlD
Lisuride—Ergonovine—HTR2C—metabolic syndrome X	0.00212	0.212	CrCbGaD
Lisuride—HTR2A—artery—metabolic syndrome X	0.002	0.0356	CbGeAlD
Lisuride—ADRA1B—kidney—metabolic syndrome X	0.00187	0.0333	CbGeAlD
Lisuride—Methylergometrine—HTR2C—metabolic syndrome X	0.00185	0.185	CrCbGaD
Lisuride—Cabergoline—HTR2C—metabolic syndrome X	0.00185	0.185	CrCbGaD
Lisuride—HTR2A—endothelium—metabolic syndrome X	0.00169	0.0301	CbGeAlD
Lisuride—HTR2A—blood vessel—metabolic syndrome X	0.00156	0.0277	CbGeAlD
Lisuride—Methysergide—HTR2C—metabolic syndrome X	0.00155	0.155	CrCbGaD
Lisuride—HTR1B—cardiovascular system—metabolic syndrome X	0.00144	0.0257	CbGeAlD
Lisuride—Pergolide—HTR2C—metabolic syndrome X	0.00143	0.143	CrCbGaD
Lisuride—HTR1D—cardiovascular system—metabolic syndrome X	0.0014	0.0249	CbGeAlD
Lisuride—HTR1D—kidney—metabolic syndrome X	0.00137	0.0244	CbGeAlD
Lisuride—ADRB1—cardiovascular system—metabolic syndrome X	0.00136	0.0242	CbGeAlD
Lisuride—HTR2B—cardiovascular system—metabolic syndrome X	0.0013	0.0232	CbGeAlD
Lisuride—ADRB1—adipose tissue—metabolic syndrome X	0.0012	0.0213	CbGeAlD
Lisuride—Ergotamine—HTR2C—metabolic syndrome X	0.00119	0.119	CrCbGaD
Lisuride—HTR1A—cardiovascular system—metabolic syndrome X	0.00117	0.0208	CbGeAlD
Lisuride—HTR2B—adipose tissue—metabolic syndrome X	0.00115	0.0204	CbGeAlD
Lisuride—ADRA2C—kidney—metabolic syndrome X	0.001	0.0178	CbGeAlD
Lisuride—ADRA2C—adipose tissue—metabolic syndrome X	0.000902	0.0161	CbGeAlD
Lisuride—ADRA2A—adipose tissue—metabolic syndrome X	0.00072	0.0128	CbGeAlD
Lisuride—HTR2A—cardiovascular system—metabolic syndrome X	0.000694	0.0124	CbGeAlD
Lisuride—HTR2A—kidney—metabolic syndrome X	0.000679	0.0121	CbGeAlD
Lisuride—ADRA2C—liver—metabolic syndrome X	0.000633	0.0113	CbGeAlD
Lisuride—CYP3A4—kidney—metabolic syndrome X	0.000629	0.0112	CbGeAlD
Lisuride—CYP2D6—kidney—metabolic syndrome X	0.000619	0.011	CbGeAlD
Lisuride—HTR2A—liver—metabolic syndrome X	0.000429	0.00765	CbGeAlD
Lisuride—CYP3A4—liver—metabolic syndrome X	0.000398	0.00708	CbGeAlD
Lisuride—CYP2D6—liver—metabolic syndrome X	0.000391	0.00697	CbGeAlD
Lisuride—DRD4—Signaling Pathways—NOS3—metabolic syndrome X	1.57e-05	0.000114	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.57e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—LEP—metabolic syndrome X	1.57e-05	0.000114	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—APOE—metabolic syndrome X	1.57e-05	0.000114	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCL2—metabolic syndrome X	1.56e-05	0.000113	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IGF1—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AGT—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	1.55e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—APOA1—metabolic syndrome X	1.55e-05	0.000112	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	1.55e-05	0.000112	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLA2G6—metabolic syndrome X	1.54e-05	0.000112	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	1.54e-05	0.000112	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	1.54e-05	0.000112	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IGF1—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IGF1—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOA5—metabolic syndrome X	1.53e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	1.52e-05	0.00011	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—APOE—metabolic syndrome X	1.52e-05	0.00011	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	1.52e-05	0.00011	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	1.51e-05	0.000109	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ABCA1—metabolic syndrome X	1.51e-05	0.000109	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—SLC2A4—metabolic syndrome X	1.51e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—APOA1—metabolic syndrome X	1.5e-05	0.000109	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	1.5e-05	0.000108	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NOS3—metabolic syndrome X	1.49e-05	0.000108	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.48e-05	0.000107	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—ALB—metabolic syndrome X	1.47e-05	0.000106	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GGT1—metabolic syndrome X	1.46e-05	0.000106	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GOT1—metabolic syndrome X	1.46e-05	0.000106	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	1.46e-05	0.000106	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—SERPINE1—metabolic syndrome X	1.46e-05	0.000106	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AGT—metabolic syndrome X	1.45e-05	0.000105	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—INS—metabolic syndrome X	1.45e-05	0.000105	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IRS1—metabolic syndrome X	1.44e-05	0.000105	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IRS1—metabolic syndrome X	1.44e-05	0.000104	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	1.43e-05	0.000104	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AGT—metabolic syndrome X	1.43e-05	0.000103	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	1.42e-05	0.000103	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—TRIB3—metabolic syndrome X	1.42e-05	0.000103	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—APOE—metabolic syndrome X	1.42e-05	0.000103	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—LEP—metabolic syndrome X	1.42e-05	0.000103	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NOS3—metabolic syndrome X	1.41e-05	0.000102	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	1.41e-05	0.000102	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—APOA1—metabolic syndrome X	1.4e-05	0.000102	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TGFB1—metabolic syndrome X	1.4e-05	0.000102	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—NOS3—metabolic syndrome X	1.4e-05	0.000102	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—LEP—metabolic syndrome X	1.4e-05	0.000101	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—APOE—metabolic syndrome X	1.4e-05	0.000101	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	1.4e-05	0.000101	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	1.4e-05	0.000101	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.39e-05	0.000101	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-05	0.000101	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NOS3—metabolic syndrome X	1.39e-05	0.000101	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	1.38e-05	0.0001	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—INS—metabolic syndrome X	1.38e-05	0.0001	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—APOA1—metabolic syndrome X	1.38e-05	0.0001	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—INS—metabolic syndrome X	1.38e-05	9.98e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	1.37e-05	9.97e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—metabolic syndrome X	1.37e-05	9.94e-05	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.36e-05	9.89e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCL2—metabolic syndrome X	1.36e-05	9.87e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCL2—metabolic syndrome X	1.35e-05	9.81e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—metabolic syndrome X	1.34e-05	9.74e-05	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—AKT1—metabolic syndrome X	1.34e-05	9.73e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	1.34e-05	9.7e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IGF1—metabolic syndrome X	1.34e-05	9.7e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IGF1—metabolic syndrome X	1.33e-05	9.65e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	1.33e-05	9.63e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PPARG—metabolic syndrome X	1.32e-05	9.61e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—metabolic syndrome X	1.32e-05	9.58e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	1.32e-05	9.55e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	1.32e-05	9.55e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.32e-05	9.54e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—INS—metabolic syndrome X	1.3e-05	9.42e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	1.3e-05	9.41e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	1.3e-05	9.4e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	1.29e-05	9.38e-05	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	1.29e-05	9.37e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	1.28e-05	9.31e-05	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.28e-05	9.29e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NAMPT—metabolic syndrome X	1.27e-05	9.25e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	1.27e-05	9.24e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	1.27e-05	9.22e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	1.27e-05	9.22e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.27e-05	9.21e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IRS1—metabolic syndrome X	1.27e-05	9.19e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	1.27e-05	9.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GCK—metabolic syndrome X	1.27e-05	9.19e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—LIPC—metabolic syndrome X	1.27e-05	9.19e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.26e-05	9.17e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.26e-05	9.16e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—metabolic syndrome X	1.26e-05	9.15e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOC3—metabolic syndrome X	1.26e-05	9.13e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	1.26e-05	9.12e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	1.26e-05	9.11e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IRS1—metabolic syndrome X	1.25e-05	9.05e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—AKT1—metabolic syndrome X	1.24e-05	8.98e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOB—metabolic syndrome X	1.24e-05	8.98e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	1.23e-05	8.91e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CETP—metabolic syndrome X	1.22e-05	8.86e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—AKT1—metabolic syndrome X	1.22e-05	8.84e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—INS—metabolic syndrome X	1.21e-05	8.8e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NOS3—metabolic syndrome X	1.21e-05	8.79e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	1.21e-05	8.77e-05	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.21e-05	8.76e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NOS3—metabolic syndrome X	1.21e-05	8.75e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PLA2G4A—metabolic syndrome X	1.2e-05	8.74e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—INS—metabolic syndrome X	1.19e-05	8.66e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCL2—metabolic syndrome X	1.19e-05	8.66e-05	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-05	8.65e-05	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—AKT1—metabolic syndrome X	1.19e-05	8.65e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—ALB—metabolic syndrome X	1.19e-05	8.64e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—metabolic syndrome X	1.19e-05	8.62e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—LPL—metabolic syndrome X	1.18e-05	8.58e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCL2—metabolic syndrome X	1.17e-05	8.52e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IGF1—metabolic syndrome X	1.17e-05	8.52e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	1.17e-05	8.51e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—metabolic syndrome X	1.17e-05	8.51e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	1.17e-05	8.51e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SCARB1—metabolic syndrome X	1.17e-05	8.49e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—AKT1—metabolic syndrome X	1.16e-05	8.44e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IGF1—metabolic syndrome X	1.16e-05	8.38e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	1.15e-05	8.37e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—NOS3—metabolic syndrome X	1.14e-05	8.27e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SREBF1—metabolic syndrome X	1.14e-05	8.24e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	1.13e-05	8.23e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—CD36—metabolic syndrome X	1.12e-05	8.15e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—SERPINE1—metabolic syndrome X	1.11e-05	8.09e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—HMGCR—metabolic syndrome X	1.11e-05	8.02e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GOT2—metabolic syndrome X	1.11e-05	8.02e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—AKT1—metabolic syndrome X	1.1e-05	7.96e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—SERPINE1—metabolic syndrome X	1.1e-05	7.96e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	1.09e-05	7.88e-05	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	1.09e-05	7.88e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-05	7.85e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—AKT1—metabolic syndrome X	1.08e-05	7.85e-05	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	1.08e-05	7.81e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TGFB1—metabolic syndrome X	1.07e-05	7.79e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	1.07e-05	7.75e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	1.07e-05	7.75e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NOS3—metabolic syndrome X	1.06e-05	7.72e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	1.06e-05	7.68e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—metabolic syndrome X	1.06e-05	7.67e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TGFB1—metabolic syndrome X	1.05e-05	7.63e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	1.05e-05	7.62e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NOS3—metabolic syndrome X	1.05e-05	7.6e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARA—metabolic syndrome X	1.04e-05	7.58e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	1.04e-05	7.56e-05	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—AKT1—metabolic syndrome X	1.04e-05	7.53e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TGFB1—metabolic syndrome X	1.04e-05	7.51e-05	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.03e-05	7.5e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—metabolic syndrome X	1.02e-05	7.42e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—metabolic syndrome X	1.02e-05	7.38e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AGT—metabolic syndrome X	1.01e-05	7.34e-05	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	1.01e-05	7.29e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	9.98e-06	7.24e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOE—metabolic syndrome X	9.91e-06	7.19e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	9.89e-06	7.18e-05	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	9.89e-06	7.18e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—metabolic syndrome X	9.88e-06	7.17e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	9.86e-06	7.15e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ABCA1—metabolic syndrome X	9.85e-06	7.15e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—SLC2A4—metabolic syndrome X	9.85e-06	7.15e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—APOA1—metabolic syndrome X	9.8e-06	7.11e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	9.77e-06	7.09e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AKT1—metabolic syndrome X	9.75e-06	7.07e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	9.74e-06	7.06e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GOT1—metabolic syndrome X	9.54e-06	6.92e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GGT1—metabolic syndrome X	9.54e-06	6.92e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	9.53e-06	6.91e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AKT1—metabolic syndrome X	9.43e-06	6.84e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AKT1—metabolic syndrome X	9.38e-06	6.81e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—metabolic syndrome X	9.32e-06	6.76e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	9.2e-06	6.67e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—metabolic syndrome X	9.2e-06	6.67e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	9.13e-06	6.62e-05	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AKT1—metabolic syndrome X	9.12e-06	6.62e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	8.98e-06	6.52e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—metabolic syndrome X	8.98e-06	6.51e-05	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.97e-06	6.51e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—metabolic syndrome X	8.83e-06	6.41e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARG—metabolic syndrome X	8.63e-06	6.26e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—INS—metabolic syndrome X	8.47e-06	6.14e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	8.38e-06	6.08e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	8.3e-06	6.02e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AKT1—metabolic syndrome X	8.28e-06	6.01e-05	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	8.16e-06	5.92e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AKT1—metabolic syndrome X	8.15e-06	5.91e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—metabolic syndrome X	8.1e-06	5.87e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOB—metabolic syndrome X	8.1e-06	5.87e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	8.04e-06	5.83e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—metabolic syndrome X	8.02e-06	5.81e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.97e-06	5.78e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—metabolic syndrome X	7.93e-06	5.75e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PLA2G4A—metabolic syndrome X	7.87e-06	5.71e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—metabolic syndrome X	7.8e-06	5.66e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—ALB—metabolic syndrome X	7.76e-06	5.63e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	7.76e-06	5.63e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—LPL—metabolic syndrome X	7.73e-06	5.61e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	7.63e-06	5.54e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AKT1—metabolic syndrome X	7.47e-06	5.42e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—metabolic syndrome X	7.45e-06	5.4e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—NOS3—metabolic syndrome X	7.42e-06	5.39e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	7.41e-06	5.38e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—CD36—metabolic syndrome X	7.34e-06	5.33e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AKT1—metabolic syndrome X	7.31e-06	5.31e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AKT1—metabolic syndrome X	7.2e-06	5.22e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—metabolic syndrome X	7.04e-06	5.1e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—metabolic syndrome X	7.02e-06	5.1e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	6.93e-06	5.03e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—metabolic syndrome X	6.93e-06	5.03e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.92e-06	5.02e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AKT1—metabolic syndrome X	6.87e-06	4.98e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARA—metabolic syndrome X	6.83e-06	4.95e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PTGS2—metabolic syndrome X	6.79e-06	4.93e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AGT—metabolic syndrome X	6.61e-06	4.8e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AKT1—metabolic syndrome X	6.48e-06	4.7e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOE—metabolic syndrome X	6.48e-06	4.7e-05	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AKT1—metabolic syndrome X	6.45e-06	4.68e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—APOA1—metabolic syndrome X	6.4e-06	4.65e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	6.39e-06	4.64e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AKT1—metabolic syndrome X	6.39e-06	4.64e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	6.31e-06	4.58e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	6.3e-06	4.57e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	6.26e-06	4.54e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—metabolic syndrome X	6.04e-06	4.38e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—metabolic syndrome X	6.01e-06	4.36e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	5.84e-06	4.24e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	5.83e-06	4.23e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	5.77e-06	4.19e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	5.75e-06	4.17e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARG—metabolic syndrome X	5.64e-06	4.09e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKT1—metabolic syndrome X	5.57e-06	4.04e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKT1—metabolic syndrome X	5.54e-06	4.02e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—INS—metabolic syndrome X	5.54e-06	4.02e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	5.39e-06	3.91e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	5.31e-06	3.85e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—metabolic syndrome X	5.3e-06	3.85e-05	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AKT1—metabolic syndrome X	5.24e-06	3.8e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—metabolic syndrome X	5.22e-06	3.79e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ALB—metabolic syndrome X	5.07e-06	3.68e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKT1—metabolic syndrome X	4.89e-06	3.55e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—NOS3—metabolic syndrome X	4.85e-06	3.52e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKT1—metabolic syndrome X	4.81e-06	3.49e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	4.75e-06	3.44e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PTGS2—metabolic syndrome X	4.44e-06	3.22e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	4.38e-06	3.18e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AKT1—metabolic syndrome X	3.41e-06	2.48e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AKT1—metabolic syndrome X	2.23e-06	1.62e-05	CbGpPWpGaD
